Latest U.S. Army Medical Research Institute of Infectious Diseases Stories
BioInnovation Solutions and USAMRIID Develop DNA Sequencing Technology for Rapid Detection and Biosurveillance of Ebola Virus CRADA funded Study published in PLOS One LAUSANNE,
AUSTIN, Texas, Aug. 4, 2014 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that U.S.
Army scientists and industry collaborators have successfully protected laboratory animals from lethal hantavirus disease using a novel approach that combines DNA vaccines and duck eggs.
Army scientists have demonstrated, for the first time, that antibody-based therapies can successfully protect monkeys from the deadly Ebola and Marburg viruses.
Vaccination with the anthrax capsule—a naturally occurring component of the bacterium that causes the disease—protected monkeys from lethal anthrax infection.
QUEBEC CITY, May 26, 2011 /PRNewswire/ - Medicago Inc.
Army scientists have discovered a way to "trick" the bacterium that causes anthrax into shedding its protective covering, making it easier for the body's immune system to mount a defense.
Research published by Army scientists indicates that a minor reduction in levels of one particular gene, known as CD45, can provide protection against two divergent microbes: the virus that causes Ebola hemorrhagic fever and the bacterium that causes anthrax
- An armed gangster.